Scientists have identified a gene — FOXC1 — that, if switched on, causes more aggressive cancer in a fifth of acute myeloid leukemia (AML) patients, according to a study.
Scientists have identified a gene — FOXC1 — that, if switched on, causes more aggressive cancer in a fifth of acute myeloid leukemia (AML) patients, according to a study.